Stocks / Biotech
CGONBiotech
CG Oncology, Inc. Common stock
$75.621d +2.0%5d +5.0%settled close · 2026-09-17
Mkt cap $5.4B (3/25)β 1.1952w $33–81Shares 84.4MInd. Biological Products, (No Diagnostic Substances)Nasdaq since 2024Emp. 142HQ Irvine, CAcgoncology.com
Who’s talkingIdea Scout · free
Who’s talking about CGON
No tracked investor commentary on CGON yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 12 Nov 2026
Confirmed date · consensus EPS -0.86. Reactions below are the next settled session over the prior close.
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where CGON’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 17 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-17 | ||||||
| 2026-09-11 | ||||||
| 2026-09-10 | ||||||
| 2026-09-09 | ||||||
| 2026-08-04 | ||||||
| 2026-06-29 | ||||||
| 2026-06-25 | ||||||
| 2026-06-09 | ||||||
| 2026-05-26 | ||||||
| 2026-04-29 | ||||||
| 2026-04-28 | ||||||
| 2026-04-20 | ||||||
| 2026-04-17 | ||||||
| 2026-04-16 | ||||||
| 2026-04-15 | ||||||
| 2026-04-14 | ||||||
| 2026-04-07 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
CGON is in this morning’s Brief.
Get The Brief — $20/mo →